Literature DB >> 15753431

The cognitive burden of multiple sclerosis in children.

Brenda L Banwell1, Peter E Anderson.   

Abstract

Little is known about the cognitive sequelae of pediatric-onset multiple sclerosis (MS). Ten pediatric patients with MS were evaluated using a comprehensive neuropsychological battery. Neuropsychological deficits were identified on measures of general cognition, language, visuomotor integration, and verbal and visual memory. Cognitive impairment occurs in children with MS, and those with longer disease duration and younger age at MS onset appear to be at greatest risk.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15753431     DOI： 10.1212/01.WNL.0000152896.35341.51

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  35 in total

1.  Psychosocial issue in children and adolescents with multiple sclerosis.

Authors:  B Goretti; A Ghezzi; E Portaccio; S Lori; V Zipoli; L Razzolini; L Moiola; M Falautano; M F De Caro; R Viterbo; F Patti; R Vecchio; C Pozzilli; V Bianchi; M Roscio; G Comi; M Trojano; M P Amato
Journal:  Neurol Sci       Date:  2010-05-08       Impact factor: 3.307

2.  Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.

Authors:  L E Charvet; E H O'Donnell; A L Belman; T Chitnis; J M Ness; J Parrish; M Patterson; M Rodriguez; E Waubant; B Weinstock-Guttman; L B Krupp
Journal:  Mult Scler       Date:  2014-03-31       Impact factor: 6.312

Review 3.  Pediatric multiple sclerosis.

Authors:  E Ann Yeh; Tanuja Chitnis; Lauren Krupp; Jayne Ness; Dorothée Chabas; Nancy Kuntz; Emmanuelle Waubant
Journal:  Nat Rev Neurol       Date:  2009-10-13       Impact factor: 42.937

Review 4.  Therapies for multiple sclerosis: considerations in the pediatric patient.

Authors:  Brenda Banwell; Amit Bar-Or; Gavin Giovannoni; Russell C Dale; Marc Tardieu
Journal:  Nat Rev Neurol       Date:  2011-01-11       Impact factor: 42.937

5.  Pediatric multiple sclerosis.

Authors:  Yashma Patel; Vikram Bhise; Lauren Krupp
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

6.  Treatment of pediatric multiple sclerosis.

Authors:  Sona Narula; Sarah E Hopkins; Brenda Banwell
Journal:  Curr Treat Options Neurol       Date:  2015-03       Impact factor: 3.598

Review 7.  Disease-modifying therapy of pediatric multiple sclerosis.

Authors:  Tanuja Chitnis
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

Review 8.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

9.  Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network.

Authors:  Laura Julian; Dana Serafin; Leigh Charvet; Joseph Ackerson; Ralph Benedict; Ellen Braaten; Tanya Brown; Ellen O'Donnell; Joy Parrish; Thomas Preston; Michael Zaccariello; Anita Belman; Tanuja Chitnis; Mark Gorman; Jayne Ness; Marc Patterson; Moses Rodriguez; Emmanuelle Waubant; Bianca Weinstock-Guttman; Ann Yeh; Lauren B Krupp
Journal:  J Child Neurol       Date:  2012-11-15       Impact factor: 1.987

10.  No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab.

Authors:  Monica Margoni; Francesca Rinaldi; Alice Riccardi; Silvia Franciotta; Paola Perini; Paolo Gallo
Journal:  J Neurol       Date:  2019-09-27       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.